OMTX-503

N/A

Report date: 2024/02/05 13:59:42

Base Information

Drug NameOMTX-503
Drug Alias NameMTX3-NIG
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linker > SMPT linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Nigrin-b A chain payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionRibosome inactivating proteins modulatorsAnti-CD105
TargetsRibosome inactivating proteinsEndoglin
Therapy Area/IndicationsPancreatic NeoplasmsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOncomatryx Biopharma Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncomatryx Biopharma Sl
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsSarcoma, Ewing

Other Information

ATC CodeN/A
Related LinksN/A